This work presents the characterisation of which molecular and behavioural capabilities are spared and impaired in the Dlg2 heterozygous rat model; a model with direct clinical relevance to CNVs that increase risk for a variety of psychiatric conditions including schizophrenia,3 autism1 and intellectual disability.2 Here, DLG2 is linked to schizophrenia.